What we are studying
The Wake Forest University Health Sciences Comprehensive Cancer is currently having subjects with cancer submit tumor samples and biopsies to Foundation Medicine in order to perform genomic DNA sequencing in order to identify genetic variations that may guide cancer therapy. This process has been ongoing since 2015 and genetic data and accompanying clinical data are available from subjects who have already undergone genomic DNA sequencing. Additional subjects are being screened by their oncologist and will be undergoing genomic DNA sequencing. The cumulative analysis of this genomic sequencing data together with the accompanying clinical data may help use better understand how genetic variations influence the development of cancer and may reveal important information on which cancer therapies.